D-0656-2024 Class II Ongoing

Recalled by ProRx LLC — Exton, PA

FDA drug recall D-0656-2024 was initiated by ProRx LLC on Aug 22, 2024 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is ongoing. Affected quantity: 1,732 vials.

Recall details

Product Type
Drugs
Report Date
Sep 11, 2024
Initiation Date
Aug 22, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1,732 vials

Product description

TIRZEPATIDE 60 mg/3mL (20/mg/mL), Rx Only, 3mL Multiple Dose Vial, Mfd by: ProRx Exton, PA, 19341, NDC 84139-210-02

Reason for recall

Lack of Assurance of Sterility

Distribution pattern

Nationwide in the USA

Code information

Lot# ProRx052224, BUD 11/21/2024 ProRx061024, BUD 12/09/2024

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0656-2024
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0656-2024. Report a data issue: hello@regdatalab.com.